• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[应用钌(RU 106 Rh 106)治疗100例脉络膜和睫状体黑色素瘤的评估]

[Evaluation of 100 melanomas of the choroid and ciliary body treated by application of ruthenium (RU 106 Rh 106)].

作者信息

Grange J D, Gerard J P, Ragab M, Quintero P, Delaroche G, Jean-Louis B, Sentenac I, Fontaniere B, Bievelez B

出版信息

Bull Soc Ophtalmol Fr. 1989 May;89(5):679-82.

PMID:2590984
Abstract

100 cases of uveal melanomas, were treated with 106 RU 106 RH beta-brachytherapy, between June 1983 and September 1987. 82 eyes having a follow-up superior or equal to 6 months, were analysed. 13 of these 82 eyes have been enucleated. 2 patients, have died, 2 have at this time, hepatic dissemination. The first 43 patients were analysed at the 18th month after irradiation. The majority of tumors with initial thickness inferior to 5 mm had a regression superior to 50%, at the 18th month. The majority of tumors with initial thickness superior to 5 mm, had a regression inferior to 50%, at the same time. Functional results have also been noticed in this series of 43 eyes, and were satisfactory.

摘要

1983年6月至1987年9月期间,100例葡萄膜黑色素瘤患者接受了106Ru和106Rhβ近距离放射治疗。对82只随访时间不少于6个月的眼睛进行了分析。这82只眼中有13只已被摘除眼球。2例患者死亡,2例目前有肝转移。对前43例患者在放疗后第18个月进行了分析。大多数初始厚度小于5mm的肿瘤在第18个月时缩小超过50%。大多数初始厚度大于5mm的肿瘤在同一时间缩小不到50%。在这43只眼中还观察到了功能结果,且结果令人满意。

相似文献

1
[Evaluation of 100 melanomas of the choroid and ciliary body treated by application of ruthenium (RU 106 Rh 106)].[应用钌(RU 106 Rh 106)治疗100例脉络膜和睫状体黑色素瘤的评估]
Bull Soc Ophtalmol Fr. 1989 May;89(5):679-82.
2
[The role of beta-ray therapy in the treatment of choroidal and ciliary body melanomas].[β射线疗法在脉络膜和睫状体黑色素瘤治疗中的作用]
Ophtalmologie. 1989 Jun-Aug;3(3):175-9.
3
Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years' experience with beta-rays).钌近距离放射治疗脉络膜和睫状体黑色素瘤的长期生存、解剖学及功能结果(15年β射线治疗经验)
Am J Ophthalmol. 2004 May;137(5):893-900. doi: 10.1016/j.ajo.2003.12.032.
4
Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population.1979年至2003年期间瑞典人群中葡萄膜黑色素瘤的钌近距离放射治疗:生存及功能结果
Ophthalmology. 2005 May;112(5):834-40. doi: 10.1016/j.ophtha.2004.11.038.
5
Predicting local control of choroidal melanomas following ¹⁰⁶Ru plaque brachytherapy.预测¹⁰⁶Ru 放射性敷贴治疗后脉络膜黑色素瘤的局部控制情况。
Br J Ophthalmol. 2011 Feb;95(2):166-70. doi: 10.1136/bjo.2009.176198. Epub 2010 Oct 1.
6
[Comparative study of the tumor regression rate of 127 uveal melanomas irradiated with 106 Ru/106 Rh. Attempted analysis of the correlations between per-operative cytology and histopathology of the enucleated eye and the tumoral regression on the one hand, and general prognosis on the other hand].
Ophtalmologie. 1990 May-Jun;4(3):221-4.
7
Malignant melanomas of the choroid and ruthenium applicators.脉络膜恶性黑色素瘤与钌施源器
Bull Soc Belge Ophtalmol. 1990;238:137-43.
8
[Long-term results of cobalt 60 curietherapy for uveal melanoma].[钴60敷贴治疗葡萄膜黑色素瘤的长期疗效]
J Fr Ophtalmol. 1998 May;21(5):333-44.
9
Ruthenium plaque radiation therapy for iris and iridociliary melanomas.钌 106 放射性敷贴治疗虹膜和睫状体黑色素瘤。
Acta Ophthalmol. 2012 May;90(3):291-6. doi: 10.1111/j.1755-3768.2010.01967.x. Epub 2010 Jul 29.
10
[Curietherapy using a ruthenium and iridium disk in the treatment of choroid melanoma].[使用钌和铱盘进行居里疗法治疗脉络膜黑色素瘤]
Ann Radiol (Paris). 1989;32(2):107-11.

引用本文的文献

1
Survival after primary enucleation for choroidal melanoma: changes induced by the introduction of conservative therapies.脉络膜黑色素瘤原发眼球摘除术后的生存率:保守治疗引入所带来的变化。
Graefes Arch Clin Exp Ophthalmol. 2007 May;245(5):657-63. doi: 10.1007/s00417-006-0477-1. Epub 2006 Nov 22.